Ginkgo Bioworks (DNA) is down -12.5%, or -$1.29 to $9.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DNA:
- Ginkgo Bioworks price target lowered to $12 from $16 at TD Cowen
- Cautious Outlook on Ginkgo Bioworks: Sell Rating Amid Financial and Strategic Concerns
- Ginkgo Bioworks Holdings: Buy Rating Affirmed Amid Growth Potential in Tools and AI Offerings Despite Price Target Reduction
- Ginkgo Bioworks Reports Improved Q4 2024 Results
- Ginkgo Bioworks sees FY25 revenue $160M-$180M, consensus $203.81M